Enzyme (MLN) Price Prediction

Deep Dive

1. Exchange Delistings & Liquidity Crunch (Bearish Impact)

Overview: MLN's trading accessibility has been severely damaged. Binance, the world's largest exchange, delisted MLN from spot trading on May 27, 2026. Bybit followed, delisting its perpetual futures contracts on June 26. These actions, typically due to low liquidity and volume, force holders onto smaller venues, drastically reducing market depth and increasing price slippage.

What this means: The loss of major trading venues is a severe bearish overhang. It restricts the investor base, amplifies price impact on trades, and fosters negative sentiment, making a sustained recovery difficult without relisting on a top-tier exchange.

2. Tokenomics: Inflationary Minting vs. Fee Burns (Mixed Impact)

Overview: MLN's value accrual is a tug-of-war. Users pay fees in MLN (0.25% of vault AUM), which are then burned, creating deflationary pressure (Tokenomics | Enzyme Documentation). However, the protocol mints up to 300,600 new MLN annually for development grants. The documentation itself notes that "inflation is likely to exceed the amount burnt for many years to come."

What this means: This structure is net inflationary in the near-to-medium term, diluting per-token value. For MLN's price to rise structurally, growth in platform AUM and fee generation must outpace the annual mint, a high bar requiring massive adoption.

3. Institutional Adoption of On-Chain Finance (Bullish Impact)

Overview: Enzyme is actively pursuing institutional use cases. It partners with asset managers like CV5 Capital, who use its Onyx tech stack. It's also a launch partner on networks like Rayls and integrates with privacy-focused Canton Network, targeting traditional finance.

What this means: Successful onboarding of large-scale asset managers would directly increase fee-generating AUM, accelerating the burn rate and creating tangible demand for MLN tokens. This is the primary long-term bullish narrative, though its realization is uncertain and gradual.

Conclusion

MLN's immediate future is constrained by poor liquidity and inflationary supply, but its long-term thesis hinges on becoming essential infrastructure for tokenized funds. For a typical holder, patience is required to see if institutional partnerships can translate into meaningful usage and token demand.

Can Enzyme attract enough AUM to its vaults to flip its tokenomics from inflationary to deflationary?